[go: up one dir, main page]

DZ2649A1 - Association of active principles for the treatment of senile dementia of the alzheimer type. - Google Patents

Association of active principles for the treatment of senile dementia of the alzheimer type.

Info

Publication number
DZ2649A1
DZ2649A1 DZ980259A DZ980259A DZ2649A1 DZ 2649 A1 DZ2649 A1 DZ 2649A1 DZ 980259 A DZ980259 A DZ 980259A DZ 980259 A DZ980259 A DZ 980259A DZ 2649 A1 DZ2649 A1 DZ 2649A1
Authority
DZ
Algeria
Prior art keywords
association
treatment
senile dementia
active principles
alzheimer type
Prior art date
Application number
DZ980259A
Other languages
French (fr)
Inventor
Jean-Pierre Maffrand
Philippe Soubrie
Jean-Paul Terranova
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9714322A external-priority patent/FR2771007B1/en
Priority claimed from FR9714324A external-priority patent/FR2771006B1/en
Application filed by Sanofi Sa filed Critical Sanofi Sa
Application granted granted Critical
Publication of DZ2649A1 publication Critical patent/DZ2649A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/64Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DZ980259A 1997-11-14 1998-11-11 Association of active principles for the treatment of senile dementia of the alzheimer type. DZ2649A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9714322A FR2771007B1 (en) 1997-11-14 1997-11-14 COMBINATION OF ACTIVE INGREDIENTS FOR THE TREATMENT OF SENILE DEMENTIA OF THE ALZHEIMER TYPE
FR9714324A FR2771006B1 (en) 1997-11-14 1997-11-14 COMBINATION OF ACTIVE INGREDIENTS FOR THE TREATMENT OF SENILE DEMENTIA OF THE ALZHEIMER TYPE

Publications (1)

Publication Number Publication Date
DZ2649A1 true DZ2649A1 (en) 2004-12-28

Family

ID=26233932

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ980259A DZ2649A1 (en) 1997-11-14 1998-11-11 Association of active principles for the treatment of senile dementia of the alzheimer type.

Country Status (27)

Country Link
EP (1) EP1030671A1 (en)
JP (1) JP2001523642A (en)
KR (1) KR100599350B1 (en)
CN (1) CN1243540C (en)
AU (1) AU743228B2 (en)
BG (1) BG64819B1 (en)
BR (1) BR9814035A (en)
CA (1) CA2309966A1 (en)
CO (1) CO4980891A1 (en)
DZ (1) DZ2649A1 (en)
EA (1) EA003255B1 (en)
EE (1) EE04235B1 (en)
HU (1) HUP0100098A3 (en)
ID (1) ID24933A (en)
IL (2) IL136122A0 (en)
IS (1) IS5482A (en)
MY (1) MY120461A (en)
NO (1) NO20002450L (en)
NZ (1) NZ504420A (en)
OA (1) OA11464A (en)
PL (1) PL194597B1 (en)
SA (1) SA98190747B1 (en)
SK (1) SK286040B6 (en)
TR (1) TR200001262T2 (en)
TW (1) TW585766B (en)
UY (1) UY25247A1 (en)
WO (1) WO1999025363A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE42327E1 (en) * 2002-06-14 2011-05-03 Toyama Chemical Co., Ltd. Medicinal compositions improving brain function and method for improving brain function
AU2003266967B2 (en) * 2002-08-07 2006-11-16 Novartis Ag Methods for the treatment of dementia based on Apo E genotype
CN1520818A (en) * 2003-02-09 2004-08-18 山东绿叶天然药物研究开发有限公司 Cholinesterase inhibitor pharmaceutical composition for senile dementia
EP1830886B1 (en) 2004-12-27 2016-04-13 Eisai R&D Management Co., Ltd. Method for stabilizing anti-dementia drug
DK3099296T3 (en) 2014-01-31 2019-04-15 Cognition Therapeutics Inc ISO-INDOLINE DERIVATIVES, COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASE
KR102614814B1 (en) 2017-05-15 2023-12-20 카그니션 테라퓨틱스, 인코퍼레이티드 Composition for treating neurodegenerative diseases
KR102224918B1 (en) 2018-03-20 2021-03-09 (주)인벤티지랩 Pharmaceutiical composition comprising memantine and donepezil for preventing or treating cognitive impairment-related disease and preparation method thereof
WO2019182319A1 (en) * 2018-03-20 2019-09-26 (주)인벤티지랩 Method for preparing pharmaceutical composition for preventing or treating cognitive disorder-associated diseases, and pharmaceutical composition for preventing or treating cognitive disorder-associated diseases, prepared by preparation method
CN109265391B (en) * 2018-11-13 2021-11-19 枣庄学院 Biphenyl polysubstituted 1,2,5, 6-tetrahydropyridine compound and synthetic method and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2662355B1 (en) * 1990-05-22 1994-11-10 Sanofi Sa USE OF 1- [2- (2-NAPHTYL) ETHYL] -4- (3-TRIFLUOROMETHYLPHENYL) -1,2,3,6-TETRAHYDROPYRIDINE FOR THE PREPARATION OF MEDICINES FOR THE TREATMENT OF BRAIN AND NEURAL DISORDERS.
US5453428A (en) * 1991-02-14 1995-09-26 The Mount Sinai School Of Medicine Of The City Of New York Method and composition for the treatment of apathy-amotivation syndrome
CA2213000A1 (en) * 1995-03-06 1996-09-12 Interneuron Pharmaceuticals, Inc. Reduction of infarct volume using citicoline
FR2736053B1 (en) * 1995-06-28 1997-09-19 Sanofi Sa NEWS 1-PHENYLALKYL-1,2,3,6-TETRAHYDROPYRIDINES

Also Published As

Publication number Publication date
IS5482A (en) 2000-05-09
CN1243540C (en) 2006-03-01
IL136122A (en) 2006-07-05
UY25247A1 (en) 2001-05-31
SA98190747B1 (en) 2006-11-04
ID24933A (en) 2000-08-31
CO4980891A1 (en) 2000-11-27
AU1160999A (en) 1999-06-07
SK7112000A3 (en) 2000-10-09
EA003255B1 (en) 2003-02-27
CA2309966A1 (en) 1999-05-27
BG64819B1 (en) 2006-05-31
NO20002450D0 (en) 2000-05-11
MY120461A (en) 2005-10-31
NZ504420A (en) 2003-08-29
HUP0100098A2 (en) 2001-07-30
IL136122A0 (en) 2001-05-20
EA200000412A1 (en) 2000-12-25
HUP0100098A3 (en) 2001-12-28
EE200000290A (en) 2001-06-15
EP1030671A1 (en) 2000-08-30
KR20010032099A (en) 2001-04-16
PL194597B1 (en) 2007-06-29
TR200001262T2 (en) 2001-01-22
AU743228B2 (en) 2002-01-24
TW585766B (en) 2004-05-01
EE04235B1 (en) 2004-02-16
NO20002450L (en) 2000-07-14
WO1999025363A1 (en) 1999-05-27
CN1285742A (en) 2001-02-28
BR9814035A (en) 2000-09-26
BG104428A (en) 2001-08-31
OA11464A (en) 2003-11-18
PL340500A1 (en) 2001-02-12
JP2001523642A (en) 2001-11-27
KR100599350B1 (en) 2006-07-12
SK286040B6 (en) 2008-01-07

Similar Documents

Publication Publication Date Title
EP0670731A4 (en) TREATMENT OF AMNESIA IN ALZHEIMER'S DISEASE CAUSED BY THE DEPOSITION OF AMYLOID G (B) PROTEIN.
ATE279407T1 (en) FSH MIMETICS FOR THE TREATMENT OF INFERTILITY
DZ3014A1 (en) Medicines for the treatment of hypertension.
FR2718351B1 (en) Process for the permanent deformation of keratin materials.
FR2721823B1 (en) Process for the permanent deformation of keratin materials
DZ2649A1 (en) Association of active principles for the treatment of senile dementia of the alzheimer type.
FR2705966B1 (en) Antifoam compositions useful in particular for the treatment of gastric disorders.
DE69607728D1 (en) Thixo casting process
PH31643A (en) 2-Oxidole-1-carboxamide pharmaceutical agents for the treatment of alzheimer's disease.
FR2694575B1 (en) PROCESS FOR THE TREATMENT OF MCRALZ COATINGS.
DZ2012A1 (en) Benzamides for the treatment of neurological degenerations.
MA25852A1 (en) METHOD FOR THE TREATMENT OF INFLAMMATION.
FR2719240B1 (en) Process for the treatment of oily suspensions.
FR2713657B1 (en) New vectors for the treatment of AIDS.
EP0667157A4 (en) SYMPTOMATIC TREATMENT OF CIRCULATORY DISORDERS.
FR2771006B1 (en) COMBINATION OF ACTIVE INGREDIENTS FOR THE TREATMENT OF SENILE DEMENTIA OF THE ALZHEIMER TYPE
FR2771007B1 (en) COMBINATION OF ACTIVE INGREDIENTS FOR THE TREATMENT OF SENILE DEMENTIA OF THE ALZHEIMER TYPE
DE60201440D1 (en) ARYL-8-AZABICYCLO [3.2.1] OCTANES FOR THE TREATMENT OF DEPRESSION
ATE345818T1 (en) S-METHYL-DIHYDRO-ZIPRASIDONE FOR THE TREATMENT OF PSYCHIATRIC DISORDERS.
FR2716803B1 (en) Process for the permanent deformation of keratin materials.
IT1281347B1 (en) SELF-STEERING RODIGGIO FOR ROTABILI ON IRON
FR2694748B1 (en) Decanter-digester for the treatment of domestic waste water.
FR2702645B1 (en) ADAPTABLE BATHTUB FOR BATHROOM.
FR2804331B1 (en) VALVE FOR THE TREATMENT OF HYDROCEPHALIA
FR2706307B1 (en) Formula for treatment of AIDS.